Literature DB >> 28707266

6-OHDA-Lesioned Adult Zebrafish as a Useful Parkinson's Disease Model for Dopaminergic Neuroregeneration.

Yuganthini Vijayanathan1,2, Fei Tieng Lim1, Siong Meng Lim1, Chiau Ming Long3, Maw Pin Tan2, Abu Bakar Abdul Majeed1, Kalavathy Ramasamy4.   

Abstract

Conventional mammalian models of neurodegeneration are often limited by futile axonogenesis with minimal functional recuperation of severed neurons. The emergence of zebrafish, a non-mammalian model with excellent neuroregenerative properties, may address these limitations. This study aimed to establish an adult zebrafish-based, neurotoxin-induced Parkinson's disease (PD) model and subsequently validate the regenerative capability of dopaminergic neurons (DpN). The DpN of adult male zebrafish (Danio rerio) were lesioned by microinjecting 6-hydroxydopamine (6-OHDA) neurotoxin (6.25, 12.5, 18.75, 25, 37.5, 50 and 100 mg/kg) into the ventral diencephalon (Dn). This was facilitated by an optimised protocol that utilised 1,1'-dioctadecyl-3,3,3',3'-tetramethyl-indocarbocyanineperchlorate (DiI) dye to precisely identify the injection site. Immunostaining was utilised to identify the number of tyrosine hydroxylase immunoreactive (TH-ir) DpN in brain regions of interest (i.e. olfactory bulb, telencephalon, preoptic area, posterior tuberculum and hypothalamus). Open tank video recordings were performed for locomotor studies. The Dn was accessed by setting the injection angle of the microinjection capillary to 60° and injection depth to 1200 μm (from the exposed brain surface). 6-OHDA (25 mg/kg) successfully ablated >85% of the Dn DpN (preoptic area, posterior tuberculum and hypothalamus) whilst maintaining a 100% survival. Locomotor analysis of 5-min recordings revealed that 6-OHDA-lesioned adult zebrafish were significantly (p < 0.0001) reduced in speed (cm/s) and distance travelled (cm). Lesioned zebrafish showed full recovery of Dn DpN 30 days post-lesion. This study had successfully developed a stable 6-OHDA-induced PD zebrafish model using a straightforward and reproducible approach. Thus, this developed teleost model poses exceptional potentials to study DpN regeneration.

Entities:  

Keywords:  6-Hydroxydopamine; Microinjection; Neurogenesis; Parkinson’s disease; Teleost; Tyrosine hydroxylase

Mesh:

Substances:

Year:  2017        PMID: 28707266     DOI: 10.1007/s12640-017-9778-x

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  87 in total

Review 1.  New functional roles for non-collagenous domains of basement membrane collagens.

Authors:  Nathalie Ortega; Zena Werb
Journal:  J Cell Sci       Date:  2002-11-15       Impact factor: 5.285

2.  Sulfation patterns of glycosaminoglycans encode molecular recognition and activity.

Authors:  Cristal I Gama; Sarah E Tully; Naoki Sotogaku; Peter M Clark; Manish Rawat; Nagarajan Vaidehi; William A Goddard; Akinori Nishi; Linda C Hsieh-Wilson
Journal:  Nat Chem Biol       Date:  2006-07-30       Impact factor: 15.040

3.  Sialome analysis of the cephalochordate Branchiostoma belcheri, a key organism for vertebrate evolution.

Authors:  Yann Guérardel; Lan-Yi Chang; Akiko Fujita; Bernadette Coddeville; Emmanuel Maes; Chihiro Sato; Anne Harduin-Lepers; Kaoru Kubokawa; Ken Kitajima
Journal:  Glycobiology       Date:  2011-11-04       Impact factor: 4.313

4.  Hydrogen sulphide regulates calcium homeostasis in microglial cells.

Authors:  Shiau Wei Lee; Ye-Shi Hu; Li-Fang Hu; Qing Lu; Gavin S Dawe; Philip K Moore; Peter T-H Wong; Jin-Song Bian
Journal:  Glia       Date:  2006-08-01       Impact factor: 7.452

Review 5.  Midbrain dopamine neuron differentiation: factors and fates.

Authors:  Asa Abeliovich; Rachel Hammond
Journal:  Dev Biol       Date:  2007-01-27       Impact factor: 3.582

6.  O-methylated glycans from Toxocara are specific targets for antibody binding in human and animal infections.

Authors:  Irma Schabussova; Hassan Amer; Irma van Die; Paul Kosma; Rick M Maizels
Journal:  Int J Parasitol       Date:  2006-10-09       Impact factor: 3.981

7.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.

Authors:  A Yayon; M Klagsbrun; J D Esko; P Leder; D M Ornitz
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

8.  Motor neuron regeneration in adult zebrafish.

Authors:  Michell M Reimer; Inga Sörensen; Veronika Kuscha; Rebecca E Frank; Chong Liu; Catherina G Becker; Thomas Becker
Journal:  J Neurosci       Date:  2008-08-20       Impact factor: 6.167

9.  Studies on the substrate specificity of a GDP-mannose pyrophosphorylase from Salmonella enterica.

Authors:  Lu Zou; Ruixiang Blake Zheng; Todd L Lowary
Journal:  Beilstein J Org Chem       Date:  2012-08-01       Impact factor: 2.883

10.  Stab wound injury of the zebrafish adult telencephalon: a method to investigate vertebrate brain neurogenesis and regeneration.

Authors:  Rebecca Schmidt; Tanja Beil; Uwe Strähle; Sepand Rastegar
Journal:  J Vis Exp       Date:  2014-08-04       Impact factor: 1.355

View more
  14 in total

1.  Regeneration of Dopaminergic Neurons in Adult Zebrafish Depends on Immune System Activation and Differs for Distinct Populations.

Authors:  Lindsey J Caldwell; Nick O Davies; Leonardo Cavone; Karolina S Mysiak; Svetlana A Semenova; Pertti Panula; J Douglas Armstrong; Catherina G Becker; Thomas Becker
Journal:  J Neurosci       Date:  2019-04-04       Impact factor: 6.167

2.  Defining the ultrastructure of the hematopoietic stem cell niche by correlative light and electron microscopy.

Authors:  Sobhika Agarwala; Keun-Young Kim; Sebastien Phan; Saeyeon Ju; Ye Eun Kong; Guillaume A Castillon; Eric A Bushong; Mark H Ellisman; Owen J Tamplin
Journal:  Elife       Date:  2022-08-09       Impact factor: 8.713

3.  Zebrafish as an Animal Model for Drug Discovery in Parkinson's Disease and Other Movement Disorders: A Systematic Review.

Authors:  Rita L Vaz; Tiago F Outeiro; Joaquim J Ferreira
Journal:  Front Neurol       Date:  2018-06-01       Impact factor: 4.003

Review 4.  Chemical and Genetic Zebrafish Models to Define Mechanisms of and Treatments for Dopaminergic Neurodegeneration.

Authors:  Ola Wasel; Jennifer L Freeman
Journal:  Int J Mol Sci       Date:  2020-08-20       Impact factor: 5.923

Review 5.  Parkinson's Disease-Induced Zebrafish Models: Focussing on Oxidative Stress Implications and Sleep Processes.

Authors:  Madalina-Andreea Robea; Ioana-Miruna Balmus; Alin Ciobica; Stefan Strungaru; Gabriel Plavan; Lucian Dragos Gorgan; Alexandra Savuca; Mircea Nicoara
Journal:  Oxid Med Cell Longev       Date:  2020-08-18       Impact factor: 6.543

Review 6.  Modeling Neuroregeneration and Neurorepair in an Aging Context: The Power of a Teleost Model.

Authors:  Jolien Van Houcke; Valerie Mariën; Caroline Zandecki; Eve Seuntjens; Rajagopal Ayana; Lutgarde Arckens
Journal:  Front Cell Dev Biol       Date:  2021-03-18

Review 7.  The Promise of the Zebrafish Model for Parkinson's Disease: Today's Science and Tomorrow's Treatment.

Authors:  Khairiah Razali; Noratikah Othman; Mohd Hamzah Mohd Nasir; Abd Almonem Doolaanea; Jaya Kumar; Wisam Nabeel Ibrahim; Norlinah Mohamed Ibrahim; Wael M Y Mohamed
Journal:  Front Genet       Date:  2021-04-15       Impact factor: 4.599

Review 8.  Adult Endogenous Dopaminergic Neuroregeneration Against Parkinson's Disease: Ideal Animal Models?

Authors:  Yuganthini Vijayanathan; Siong Meng Lim; Maw Pin Tan; Fei Ting Lim; Abu Bakar Abdul Majeed; Kalavathy Ramasamy
Journal:  Neurotox Res       Date:  2020-11-03       Impact factor: 3.911

9.  Dopaminergic neurons regenerate following chemogenetic ablation in the olfactory bulb of adult Zebrafish (Danio rerio).

Authors:  Rafael Godoy; Khang Hua; Michael Kalyn; Victoria-Marie Cusson; Hymie Anisman; Marc Ekker
Journal:  Sci Rep       Date:  2020-07-30       Impact factor: 4.379

Review 10.  Advances of Zebrafish in Neurodegenerative Disease: From Models to Drug Discovery.

Authors:  Xiaobo Wang; Jin-Bao Zhang; Kai-Jie He; Fen Wang; Chun-Feng Liu
Journal:  Front Pharmacol       Date:  2021-07-14       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.